GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Debt-to-Revenue

Qlife Holding AB (OSTO:QLIFE) Debt-to-Revenue : 62.37 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Qlife Holding AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr6.37 Mil. Qlife Holding AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr4.86 Mil. Qlife Holding AB's annualized Revenue for the quarter that ended in Sep. 2023 was kr0.18 Mil. Qlife Holding AB's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 62.37.


Qlife Holding AB Debt-to-Revenue Historical Data

The historical data trend for Qlife Holding AB's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Debt-to-Revenue Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
N/A 0.78 0.12 2.92

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.93 11.96 122.18 40.98 62.37

Competitive Comparison of Qlife Holding AB's Debt-to-Revenue

For the Medical Devices subindustry, Qlife Holding AB's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Debt-to-Revenue falls into.



Qlife Holding AB Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Qlife Holding AB's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(4.148 + 48.293) / 17.993
=2.91

Qlife Holding AB's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.371 + 4.855) / 0.18
=62.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.


Qlife Holding AB Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines